CARD9 functions in different inflammation pathways to elicit reponses to microbial signals and is known to impact intestinal inflammation. Examining the APCmin mouse model of intestinal tumorigenesis and using stringently controlled, sex- and age-matched pairs of CARD9-competent and -deficient mice, we have found that CARD9 has a restricted but strong effect on tumorigenesis in the large intestine. We have found that CARD9 reduces viability specifically in males and promotes tumorigenesis specifically in large intestine of these male mice. To our knowledge, this is the first gene ablation in APCmin mice solely affecting colon tumors in male subjects and, as such, may have significant clinical implications. Additional data suggest correlative disruption of plasma cytokine expression and immune infiltration of the tumors. We speculate that known sex-specific differences in human colorectal cancer (CRC) may involve inflammation, particularly CARD9-dependent inflammation.
- Received August 10, 2014.
- Revision received March 25, 2015.
- Accepted April 14, 2015.
- Copyright © 2015, American Association for Cancer Research.